SC 13D Filing

Company

Protagenic Therapeutics, Inc.\new

Filed

May 23, 2005

Accession Number

0000930413-05-003775

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →